Alexion To Acquire Sweden’s Wilson Therapeutics For $855M I
Alexion Pharmaceuticals (ALXN) and Wilson Therapeutics AB announced that Alexion has made a recommended public cash offer to the shareholders in Wilson Therapeutics to acquire all outstanding shares in Wilson Therapeutics by way of a tender offer, through a wholly-owned subsidiary. Wilson Therapeutics, based in Stockholm, Sweden, develops therapies for patients with rare copper-mediated disorders….